AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion

June 22, 2026 7:01 AM

AbbVie (NYSE: ABBV) has entered into a definitive agreement to acquire Apogee Therapeutics (NASDAQ: APGE) for $135.11 per share in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found